TrafFix Devices, Inc. v. Marketing Displays, Inc.

908 Devices Reports Third Quarter 2023 Financial Results and Narrows 2023 Revenue Outlook

Retrieved on: 
Tuesday, November 7, 2023

908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, today reported financial results for the quarter ended September 30, 2023.

Key Points: 
  • 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, today reported financial results for the quarter ended September 30, 2023.
  • "Handheld revenue grew 19% year to date and we expect that to further accelerate in the fourth quarter.
  • The installed base grew to 2,714 devices with 124 devices placed during the third quarter 2023.
  • 908 Devices will host a conference call to discuss the third quarter 2023 financial results before market open on Tuesday, November 7, 2023 at 5:30 am Pacific Time / 8:30 am Eastern Time.

908 Devices and Terumo Blood and Cell Technologies Collaborate to Add On-line Analytics to Quantum Flex Cell Expansion System

Retrieved on: 
Monday, November 6, 2023

908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, and medical technology company Terumo Blood and Cell Technologies (Terumo BCT) announce a collaboration to enable on-line monitoring of critical process parameters in Terumo BCT’s Quantum Flex Cell Expansion System.

Key Points: 
  • 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, and medical technology company Terumo Blood and Cell Technologies (Terumo BCT) announce a collaboration to enable on-line monitoring of critical process parameters in Terumo BCT’s Quantum Flex Cell Expansion System.
  • Cell and gene therapy developers are increasingly looking to automation to improve manufacturing efficiency, simplify workflows and reduce costs.
  • “Combining our Quantum Flex platform with 908 Devices’ on-line monitoring will help cell therapy manufacturers reduce time-consuming manual steps that increase manufacturing costs and risks,” said Kathie Schneider, Director, Global Commercial Lead, Cell Therapy Technologies at Terumo BCT.
  • “We continue to collaborate with industry experts to further enhance our solution offering to solve industry challenges.”

Announcing Aptyx: New Brand Brings Together Market-Leading Molding, Extrusion, Coatings, and Assembly Capabilities

Retrieved on: 
Tuesday, October 17, 2023

The new brand brings together the aptitude and excellence of more than a dozen companies with over 70 years of experience in complex manufacturing – particularly in the areas of molding, extrusion, coatings, and medical device assembly.

Key Points: 
  • The new brand brings together the aptitude and excellence of more than a dozen companies with over 70 years of experience in complex manufacturing – particularly in the areas of molding, extrusion, coatings, and medical device assembly.
  • The Aptyx brand will allow the company to build its commercial and operational efforts around a singular identity.
  • With integrated, specialized engineering and manufacturing capabilities, Aptyx solutions range from development through manufacturing, assembly, and packaging.
  • The organization’s logo mark is a representation of the letters A and X, an apex and the up arrow, representing continuous growth.

IDTechEx Asks, Will LCDs Be Replaced in VR

Retrieved on: 
Wednesday, September 27, 2023

It predicts the VR display market to grow at a CAGR of 7.5% to 2034, with innovation in display technology driving this growth ahead of the whole VR market.

Key Points: 
  • It predicts the VR display market to grow at a CAGR of 7.5% to 2034, with innovation in display technology driving this growth ahead of the whole VR market.
  • As this problem was solved, VR headset designers saw the other advantages of LCDs, as well as their lower cost.
  • The display industry clearly views this technology as extremely important, and IDTechEx expects OLED-on-Si to be a leading VR display technology by 2034.
  • As the VR landscape evolves, OLED-on-Si and other emerging technologies, including micro-LED, are expected to reshape the VR display landscape, eventually ending LCDs' current reign.

IDTechEx Asks, Will LCDs Be Replaced in VR

Retrieved on: 
Wednesday, September 27, 2023

It predicts the VR display market to grow at a CAGR of 7.5% to 2034, with innovation in display technology driving this growth ahead of the whole VR market.

Key Points: 
  • It predicts the VR display market to grow at a CAGR of 7.5% to 2034, with innovation in display technology driving this growth ahead of the whole VR market.
  • As this problem was solved, VR headset designers saw the other advantages of LCDs, as well as their lower cost.
  • The display industry clearly views this technology as extremely important, and IDTechEx expects OLED-on-Si to be a leading VR display technology by 2034.
  • As the VR landscape evolves, OLED-on-Si and other emerging technologies, including micro-LED, are expected to reshape the VR display landscape, eventually ending LCDs' current reign.

908 Devices Launches MAVERICK for Real-Time In-Line Monitoring of Multiple Bioprocess Parameters

Retrieved on: 
Monday, September 18, 2023

MAVERICK is the first turn-key device to utilize Raman spectroscopy for bioprocess control, with no modeling and development required.

Key Points: 
  • MAVERICK is the first turn-key device to utilize Raman spectroscopy for bioprocess control, with no modeling and development required.
  • MAVERICK offers all the advantages of Raman spectroscopy without the cost and complexities associated with conventional spectroscopic methods.
  • MAVERICK’s purpose-built de novo models automatically process Raman spectra from a wide variety of culture media types and cell lines, delivering actionable process parameters or direct process control actions.
  • MAVERICK is part of 908 Devices’ suite of devices to help expedite bioprocessing development, including MAVEN – introduced earlier this year -- and REBEL .

908 Devices Reports Second Quarter 2023 Financial Results and Updates 2023 Revenue Outlook

Retrieved on: 
Tuesday, August 8, 2023

908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, today reported financial results for the quarter ended June 30, 2023.

Key Points: 
  • 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, today reported financial results for the quarter ended June 30, 2023.
  • “We delivered solid results in the second quarter driven by robust demand for our handheld devices and strong recurring revenue,” said Kevin J. Knopp, CEO and Co-founder.
  • The installed base grew to 2,590 devices with 122 devices placed during the second quarter 2023.
  • 908 Devices will host a conference call to discuss the second quarter 2023 financial results before market open on Tuesday, August 8, 2023 at 5:30 am Pacific Time / 8:30 am Eastern Time.

908 Devices Launches Remote and Continuous Area Monitoring for Aerosol and Vapor Detection

Retrieved on: 
Monday, July 31, 2023

908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announces the launch of MX908 Beacon , a unique remote area monitoring system that can detect and identify aerosolized and vapor threats.

Key Points: 
  • 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announces the launch of MX908 Beacon , a unique remote area monitoring system that can detect and identify aerosolized and vapor threats.
  • Beacon’s area monitoring capabilities enable remote and continuous operation with more than eight hours of battery life and 16 hours of standby time.
  • “Following the groundbreaking launch of the MX908 with Aero, our customers expressed a need for more remote and continuous monitoring of aerosolized threats for a variety of applications – from hazmat area monitoring to large event protection to VIP security,” said John Kenneweg, Vice President of Government, 908 Devices.
  • To learn more about Beacon and 908 Devices, please visit: 908devices.com .

Mixed-Signal Devices Inc. Introduces the Industry’s Highest Performance Crystal Oscillator (XO) Family with 25 fs of Jitter for Frequencies up to 2 GHz

Retrieved on: 
Monday, June 12, 2023

In order to service exploding data usage across the internet networks are upgrading to higher frequencies and higher data rates.

Key Points: 
  • In order to service exploding data usage across the internet networks are upgrading to higher frequencies and higher data rates.
  • This is driving the need for higher frequency and higher performance clocks at multiple frequencies.
  • Adaptive signal processing algorithms continuously monitor performance and ensure consistent and reliable operation over process, voltage, and temperature variations.
  • For more information about the jitter, phase noise performance and evaluation boards please visit www.mixed-signal.com and contact us at [email protected]

Display Market worth $187.8 billion by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Friday, June 9, 2023

The LCD segment accounted for the largest market share in 2022 and was a relatively mature segment.

Key Points: 
  • The LCD segment accounted for the largest market share in 2022 and was a relatively mature segment.
  • However, the LCD market is expected to witness a decline during the forecast period.
  • Presence of established display panel and display device manufacturers such as Samsung Electronics Co., Ltd., LG Display Co., Ltd., BOE Technology Group Co., Ltd., etc.
  • The region influences the global display market as a majority of display panels are manufactured in South Korea, China, Taiwan, and Japan.